Prostate cancer (advanced, hormone dependent) - degarelix depot: appeal announcement
The Institute has received three appeals from:
- Ferring Pharmaceuticals Ltd
- British Uro-Oncology Group
- Tackle Prostate Cancer
The appeal hearing was held at ETC Venues, Prospero House, 241 Borough High Street, London, SE1 1GA – Wednesday 25 June 2014 at 10am.
The Institute awaits the decision of the Appeal panel.
This page was last updated: 25 June 2014